PDCT-01. BIOLOGICAL MEDICINE FOR DIFFUSE INTRINSIC PONTINE GLIOMAS ERADICATION (BIOMEDE): RESULTS OF THE THREE-ARM BIOMARKER-DRIVEN RANDOMIZED TRIAL IN THE FIRST 230 PATIENTS FROM EUROPE AND AUSTRALIA

BACKGROUND: Diffuse intrinsic pontine glioma (DIPG) is one of the most devastating brain neoplasms. Despite 50 years of clinical trials, no improvement of survival has been observed and most children die within 2 years of diagnosis. Only radiotherapy transiently controls disease progression. METHODS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Grill, Jacques, Le Teuff, Gwenael, Nysom, Karsten, Blomgren, Klas, Hargrave, Darren, McCowage, Geoff, Bautista, Francisco, van Vuurden, Dannis, Dangouloff-Ros, Volodia, Puget, Stephanie, Varlet, Pascale, Debily, Marie-Anne, Vassal, Gilles, Le Deley, Marie-Cécile
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Pediatric Clinical Trials
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847455/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.765
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados